DongKook Pharmaceutical Co. Ltd (086450) — Cash Flow Quality Index
DongKook Pharmaceutical Co. Ltd (086450) has a Cash Flow Quality Index of 0.90x as of March 2026. Operating cash flow of ₩22.58 Billion is below net income of ₩24.95 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore DongKook Pharmaceutical Co. Ltd cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
DongKook Pharmaceutical Co. Ltd Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for DongKook Pharmaceutical Co. Ltd across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 086450 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for DongKook Pharmaceutical Co. Ltd (2013–2025)
Year-by-year earnings quality comparison for DongKook Pharmaceutical Co. Ltd. For live market cap and the full company financial profile, see how much is DongKook Pharmaceutical Co. Ltd worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.04x | ₩68.76 Billion | ₩66.02 Billion | ▼ -16.2% |
| 2024 | 1.24x | ₩76.09 Billion | ₩61.22 Billion | ▲ +40.3% |
| 2023 | 0.89x | ₩41.79 Billion | ₩47.18 Billion | ▲ +14.5% |
| 2022 | 0.77x | ₩40.91 Billion | ₩52.90 Billion | ▼ -12.8% |
| 2021 | 0.89x | ₩44.65 Billion | ₩50.35 Billion | ▼ -14.0% |
| 2020 | 1.03x | ₩59.11 Billion | ₩57.29 Billion | ▼ -16.4% |
| 2019 | 1.23x | ₩69.48 Billion | ₩56.31 Billion | ▲ +74.4% |
| 2018 | 0.71x | ₩33.21 Billion | ₩46.95 Billion | ▼ -2.3% |
| 2017 | 0.72x | ₩28.66 Billion | ₩39.60 Billion | ▼ -25.3% |
| 2016 | 0.97x | ₩39.41 Billion | ₩40.69 Billion | ▼ -2.8% |
| 2015 | 1.00x | ₩27.14 Billion | ₩27.23 Billion | ▼ -7.5% |
| 2014 | 1.08x | ₩22.74 Billion | ₩21.10 Billion | ▼ -9.0% |
| 2013 | 1.18x | ₩19.86 Billion | ₩16.76 Billion | — |